Bausch Health's (BHC) Bausch + Lomb (BLCO) Files IPO

Bausch + Lomb Corporation, a leading global eye health business of Bausch Health Companies Inc. (NYSE: BHC), has publicly filed a Registration Statement on Form S-1 with the SEC for an IPO.

Shares will list on the NYSE under the ticker 'BLCO'. Neither the number of offered common shares, nor the price range for the IPO has been determined yet.

Morgan Stanley and Goldman Sachs & Co. LLC are acting as joint lead book-running managers, J.P. Morgan, Citigroup, Barclays, BofA Securities, Guggenheim Securities, Jefferies, Evercore ISI, Wells Fargo Securities and Deutsche Bank Securities as joint book-running managers, and DNB Markets, HSBC and Truist Securities as co-managers for the offering.

Bausch + Lomb's revenues for the nine months ended September 30, 2021 and 2020 were $2,764 million and $2,468 million, respectively, and the years ended 2020, 2019 and 2018 were $3,412 million, $3,778 million and $3,665 million, respectively.

You May Also Be Interested In

• Southern Cross Acquisition II prices $75M IPO on Nasdaq
• ZenaTech acquires ESM Software to expand enterprise SaaS portfolio
• Aggreko files for NYSE IPO under ticker AGKO